Free Trial

Intelligent Bio Solutions (INBS) Competitors

Intelligent Bio Solutions logo
$1.14 -0.14 (-10.55%)
As of 10:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

INBS vs. TELA, SURG, CTSO, DXR, PYPD, SRTS, MDAI, GUTS, APT, and WOK

Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include TELA Bio (TELA), SurgePays (SURG), Cytosorbents (CTSO), Daxor (DXR), PolyPid (PYPD), Sensus Healthcare (SRTS), Spectral AI (MDAI), Fractyl Health (GUTS), Alpha Pro Tech (APT), and WORK Medical Technology Group (WOK). These companies are all part of the "medical equipment" industry.

Intelligent Bio Solutions vs. Its Competitors

TELA Bio (NASDAQ:TELA) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership.

TELA Bio presently has a consensus price target of $4.50, indicating a potential upside of 212.50%. Given TELA Bio's stronger consensus rating and higher probable upside, research analysts plainly believe TELA Bio is more favorable than Intelligent Bio Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Intelligent Bio Solutions
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Intelligent Bio Solutions has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$69.30M0.82-$37.84M-$1.12-1.29
Intelligent Bio Solutions$3.05M3.41-$10.57M-$2.05-0.56

In the previous week, Intelligent Bio Solutions had 1 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Intelligent Bio Solutions and 2 mentions for TELA Bio. Intelligent Bio Solutions' average media sentiment score of 1.93 beat TELA Bio's score of 1.47 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TELA Bio
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Intelligent Bio Solutions
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by insiders. Comparatively, 1.5% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

TELA Bio has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.59, indicating that its stock price is 359% more volatile than the S&P 500.

TELA Bio has a net margin of -54.12% compared to Intelligent Bio Solutions' net margin of -346.22%. Intelligent Bio Solutions' return on equity of -231.13% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-54.12% -329.48% -57.34%
Intelligent Bio Solutions -346.22%-231.13%-108.24%

Summary

TELA Bio beats Intelligent Bio Solutions on 9 of the 16 factors compared between the two stocks.

Get Intelligent Bio Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INBS vs. The Competition

MetricIntelligent Bio SolutionsMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$10.40M$7.58B$5.68B$10.36B
Dividend YieldN/A2.77%5.75%4.64%
P/E Ratio-0.5672.0076.1026.15
Price / Sales3.4137.03550.08125.89
Price / CashN/A22.3637.5461.24
Price / Book2.796.7512.496.33
Net Income-$10.57M$245.04M$3.29B$271.03M
7 Day Performance-13.26%-1.25%0.79%0.28%
1 Month Performance-21.74%0.68%3.32%6.27%
1 Year Performance-38.11%9.81%61.19%28.42%

Intelligent Bio Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INBS
Intelligent Bio Solutions
1.13 of 5 stars
$1.15
-10.5%
N/A-33.0%$10.40M$3.05M-0.5610News Coverage
Positive News
Gap Down
TELA
TELA Bio
2.8331 of 5 stars
$1.58
flat
$4.50
+184.8%
-39.8%$62.59M$75.32M-1.41120Positive News
SURG
SurgePays
3.3782 of 5 stars
$3.05
+2.7%
$9.00
+195.1%
+83.3%$60.68M$60.88M-1.2240News Coverage
Positive News
CTSO
Cytosorbents
2.0951 of 5 stars
$0.92
-2.5%
$5.50
+500.9%
-28.8%$58.90M$35.60M-5.38220
DXR
Daxor
3.8567 of 5 stars
$11.64
-0.2%
$25.00
+114.8%
+30.4%$56.40M$3.31M0.0037Positive News
PYPD
PolyPid
3.2804 of 5 stars
$3.39
-2.3%
$12.40
+265.8%
-6.9%$55.16MN/A-0.8980Positive News
SRTS
Sensus Healthcare
2.5852 of 5 stars
$3.15
-0.9%
$8.00
+154.0%
-43.5%$52.28M$37.56M-52.5040Analyst Downgrade
MDAI
Spectral AI
2.7715 of 5 stars
$1.99
+2.6%
$3.50
+75.9%
+126.3%$51.86M$27.55M-2.8883News Coverage
Gap Up
GUTS
Fractyl Health
2.54 of 5 stars
$0.98
-3.7%
$7.15
+628.1%
-57.2%$51.30M$17K-0.48102News Coverage
High Trading Volume
APT
Alpha Pro Tech
1.546 of 5 stars
$4.84
-1.0%
N/A-13.8%$50.69M$58.56M13.08120
WOK
WORK Medical Technology Group
N/A$0.80
flat
N/A-98.2%$45.60M$11.51M0.00226News Coverage
Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:INBS) was last updated on 9/26/2025 by MarketBeat.com Staff
From Our Partners